(Q42955568)

11 November 2017

Targeting activated T cells: successful use of anti-CD25 monoclonal antibody basiliximab in a patient with systemic sclerosis (English)

1 reference

11 November 2017

1 reference

1 reference

1

1 reference

11 November 2017

3

G Riemekasten

1 reference

11 November 2017

G-R Burmester

2

1 reference

PMC publication ID

1798302

11 November 2017

language of work or name

English

0 references

publication date

1 September 2006

1 reference

Annals of the Rheumatic Diseases

11 November 2017

1 reference

11 November 2017

65

1 reference

11 November 2017

9

1 reference

11 November 2017

1245-1247

1 reference

Early T cell activation in the skin from patients with systemic sclerosis

11 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798302

Intravenous cyclophosphamide therapy for systemic sclerosis. A single-center experience and review of the literature with pooled analysis of lung function test results

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798302

Non organ based laboratory markers in systemic sclerosis

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798302

Clinical advances in therapies targeting the interleukin-2 receptor

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798302

The efficacy of oral cyclophosphamide plus prednisolone in early diffuse systemic sclerosis

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798302

Cyclophosphamide pulse regimen in the treatment of alveolitis in systemic sclerosis.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798302

Cyclophosphamide with low or high dose prednisolone for systemic sclerosis lung disease.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798302

Oligoclonal T cell expansion in the skin of patients with systemic sclerosis

16 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16905582

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Soluble interleukin-2 receptors in patients with systemic sclerosis. Clinical and laboratory correlations

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16905582

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Soluble intercellular adhesion molecule-1 (sICAM-1) and soluble interleukin-2 receptors (sIL-2R) in scleroderma skin

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16905582

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/ARD.2005.046938

1 reference

11 November 2017

1 reference

PMC publication ID

1798302

11 November 2017

PubMed publication ID

16905582

1 reference

PMC publication ID

1798302